Crossmark

Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo

Crossref DOI link: https://doi.org/10.1186/s12967-021-03225-2

Published Online: 2022-01-31

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Xiaoyun

Mo, Meile

Tan, Chao

Tan, Jennifer Hui Juan

Huang, Huishen

Liu, Bihu

Huang, Dongping

Liu, Shun

Zeng, Xiaoyun

Qiu, Xiaoqiang http://orcid.org/0000-0001-9881-3664
Funding

Funding for this research was provided by:

the National Natural Science Foundation of China (81960613, 81660563)

Natural Science Foundation of Guangxi Province (2018GXNSFBA138003)

Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Gaungxi Medical University), Ministry of Education (GKE-ZZ202001)
License Information

Text and Data Mining valid from 2022-01-31

Version of Record valid from 2022-01-31
More Information

Article History

Received: 19 November 2021

Accepted: 29 December 2021

First Online: 31 January 2022

Declarations

:

: The animal study was reviewed and approved by the Guangxi Medical University Laboratory Animal Center [SYXKGUI 2020-0004]. The studies involving human participants were reviewed and approved by the Ethics Committee of Guangxi Medical University. The patients/participants provided their written informed consent to participate in this study.

: All authors have approved the manuscript for submission.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below